PURPOSE: Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) allows rapid protein profiling of complex biological mixtures. We analyzed testicular germ cell cancer serum samples to differentiate between cancer and controls with a special focus on beta-hCG-negative seminomas. METHODS: Proteomic spectra were generated by the ProteinChip system and analyzed by the proteomic platform "proteomic.net". For statistical analysis, an artificial intelligence learning algorithm was used. RESULTS: The classification algorithm correctly identified the pattern in 90.4% of the patients. Decision trees predicted seminomas with 91.5% sensitivity and 89.4% specificity. Seminoma patients with normal beta-hCG serum level were correctly predicted with 80% sensitivity and 70% specificity. CONCLUSIONS: Our study demonstrates protein profiles of testicular germ cell cancer patients that differ in a highly significant degree from normal controls. Validation of these findings may enable proteomic profiling to become a valuable tool, especially for aftercare.
PURPOSE: Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) allows rapid protein profiling of complex biological mixtures. We analyzed testicular germ cell cancer serum samples to differentiate between cancer and controls with a special focus on beta-hCG-negative seminomas. METHODS: Proteomic spectra were generated by the ProteinChip system and analyzed by the proteomic platform "proteomic.net". For statistical analysis, an artificial intelligence learning algorithm was used. RESULTS: The classification algorithm correctly identified the pattern in 90.4% of the patients. Decision trees predicted seminomas with 91.5% sensitivity and 89.4% specificity. Seminomapatients with normal beta-hCG serum level were correctly predicted with 80% sensitivity and 70% specificity. CONCLUSIONS: Our study demonstrates protein profiles of testicular germ cell cancerpatients that differ in a highly significant degree from normal controls. Validation of these findings may enable proteomic profiling to become a valuable tool, especially for aftercare.
Authors: A Vlahou; P F Schellhammer; S Mendrinos; K Patel; F I Kondylis; L Gong; S Nasim; G L Wright Journal: Am J Pathol Date: 2001-04 Impact factor: 4.307
Authors: Jonathan Tolson; Ralf Bogumil; Elke Brunst; Hermann Beck; Raimund Elsner; Andreas Humeny; Hartmut Kratzin; Martin Deeg; Markus Kuczyk; Gerhard A Mueller; Claudia A Mueller; Thomas Flad Journal: Lab Invest Date: 2004-07 Impact factor: 5.662
Authors: Yinsheng Qu; Bao-Ling Adam; Yutaka Yasui; Michael D Ward; Lisa H Cazares; Paul F Schellhammer; Ziding Feng; O John Semmes; George L Wright Journal: Clin Chem Date: 2002-10 Impact factor: 8.327
Authors: D G Ward; N Suggett; Y Cheng; W Wei; H Johnson; L J Billingham; T Ismail; M J O Wakelam; P J Johnson; A Martin Journal: Br J Cancer Date: 2006-06-06 Impact factor: 7.640
Authors: Tim O F Conrad; Martin Genzel; Nada Cvetkovic; Niklas Wulkow; Alexander Leichtle; Jan Vybiral; Gitta Kutyniok; Christof Schütte Journal: BMC Bioinformatics Date: 2017-03-09 Impact factor: 3.169